First report 2h ago•Last update 2h ago
Australian researchers identify biomarker for high-risk blood cancer patients
Australian researchers have identified Desmoglein-2 (DSG2) as a biomarker for multiple myeloma, which could help identify high-risk patients for more personalized and effective treatment.
iWitness comments
No comments yet — be the first to weigh in.